Medicine:Hereditary cystatin C amyloid angiopathy

From HandWiki
Hereditary cystatin C amyloid angiopathy
Other namesHereditary cerebral hemorrhage with amyloidosis
Crystal structure of human cystatin C monomer.png
Cystatin C (or cystatin 3) which is involved in this condition

Hereditary cystatin C amyloid angiopathy (HCCAA) is a rare, fatal type of hereditary cerebral amyloid angiopathy found almost exclusively in Iceland. A mutation in the protein cystatin C leads to amyloid (protein aggregate) dispositions in arteries in the brain, resulting in repeated brain hemorrhages.[1][2]

The condition is inherited in an autosomal dominant fashion. All known cases have occurred in Iceland — most can be traced to Breiðafjörður in the northwest of Iceland[3] — with the exception of one patient in the US with a sporadic mutation.[4]

Symptoms are related to brain hemorrhage and include dementia and paralysis. They typically appear in the late teens or early twenties, with the average age of death being around 30.[3] As of 2019, around 20 to 30 carriers are thought to be alive.[5]

References

External links

Classification
External resources